$0.200600
0.0533.73%
Pre-Market: May 15, 9:26 AM EDT
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Nymox Pharmaceutical in recent months.
Browse guidance and forecast on all stocks.